Your browser doesn't support javascript.
loading
Corrigendum to "Huachansu capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway" [Biomed. Pharmacother. 118 (2019) 109241].
Ni, Tengyang; Wang, Haibo; Li, Dan; Tao, Li; Lv, Mengying; Jin, Feng; Wang, Weimin; Feng, Jun; Qian, Yayun; Sunagawa, Masataka; Liu, Yanqing.
Afiliação
  • Ni T; Institute of Translational Medicine, Medical College, Yangzhou University, The Key Laboratory of Syndrome Differentiation and Treatment of Gastric Cancer of the State, Administration of Traditional Chinese Medicine, Yangzhou, Jiangsu, 225001, China.
  • Wang H; Institute of Translational Medicine, Medical College, Yangzhou University, The Key Laboratory of Syndrome Differentiation and Treatment of Gastric Cancer of the State, Administration of Traditional Chinese Medicine, Yangzhou, Jiangsu, 225001, China.
  • Li D; Institute of Translational Medicine, Medical College, Yangzhou University, The Key Laboratory of Syndrome Differentiation and Treatment of Gastric Cancer of the State, Administration of Traditional Chinese Medicine, Yangzhou, Jiangsu, 225001, China.
  • Tao L; Department of Pharmacy, College of Medicine, Yangzhou University, Yangzhou, Jiangsu, 225001, China.
  • Lv M; Department of Pharmacy, College of Medicine, Yangzhou University, Yangzhou, Jiangsu, 225001, China.
  • Jin F; Institute of Translational Medicine, Medical College, Yangzhou University, The Key Laboratory of Syndrome Differentiation and Treatment of Gastric Cancer of the State, Administration of Traditional Chinese Medicine, Yangzhou, Jiangsu, 225001, China.
  • Wang W; Institute of Translational Medicine, Medical College, Yangzhou University, The Key Laboratory of Syndrome Differentiation and Treatment of Gastric Cancer of the State, Administration of Traditional Chinese Medicine, Yangzhou, Jiangsu, 225001, China.
  • Feng J; Institute of Translational Medicine, Medical College, Yangzhou University, The Key Laboratory of Syndrome Differentiation and Treatment of Gastric Cancer of the State, Administration of Traditional Chinese Medicine, Yangzhou, Jiangsu, 225001, China.
  • Qian Y; Institute of Translational Medicine, Medical College, Yangzhou University, The Key Laboratory of Syndrome Differentiation and Treatment of Gastric Cancer of the State, Administration of Traditional Chinese Medicine, Yangzhou, Jiangsu, 225001, China.
  • Sunagawa M; Department of Physiology, School of Medicine, Showa University, Tokyo 142, Japan.
  • Liu Y; Institute of Translational Medicine, Medical College, Yangzhou University, The Key Laboratory of Syndrome Differentiation and Treatment of Gastric Cancer of the State, Administration of Traditional Chinese Medicine, Yangzhou, Jiangsu, 225001, China. Electronic address: liuyq@yzu.edu.cn.
Biomed Pharmacother ; 123: 109823, 2020 03.
Article em En | MEDLINE | ID: mdl-31959384

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: França